Carol Kearney is an established commercialization executive with more than two decades of leadership experience in the biopharmaceutical industry, working with both private and publicly traded biotech companies. As Tenpoint’s first CCO, she will lead the company’s global expansion from a clinical-stage entity to a market-leading commercial organization, with an immediate focus on the potential U.S. launch of the company’s lead pipeline candidate – BRIMOCHOL™ PF.
Most recently, Kearney served as Senior Vice President, Strategy Consulting at Lumanity, Inc., formerly Clarion Healthcare, Inc., where she engaged with biopharmaceutical companies, business units and brands to define strategies to accelerate growth, overcome challenges and deliver results. During her tenure, Kearney led numerous engagements supporting clients to scale up their organizations and successfully launch new products into the marketplace. Additionally, Kearney has a robust understanding of ophthalmology and optometry having previously worked in Global Marketing for Pfizer and Pharmacia, and in sales and marketing for Bausch & Lomb as well as for a broad range of ophthalmic companies developing products for conditions affecting both the anterior and posterior segments of the eye.
